NPP

• Renal anemia (hemoglobin and cell mass increase)
• Diabetic retinopathy
• Mayo dystrophy
• Werdnig-Hoffmann spinal amyotrophy
• Breast cancer
• Glomerulonephritis
• Extensive burns
• Osteoporosis

• Cancer of the prostate
• Breast cancers (men or female)
• Allergies to anabolic steroid drugs
• Individuals with cancer and large levels of calcium supplement
• Pregnant women
• Breastfeeding women

Nandrolone Phenylpropionate can be administered only by intramuscular injection. In anemia treatment (iron preparations concurrently with) the optimal dose in men is 10-20 ml (females - 5-10 ml) one time per week; to increase anabolic processes - 5-20 ml (women - 5-10 ml) once in 1-4 weeks. The treatment length (at an interval of 1-4 weeks between injections) is up to 12 weeks; repeated treatment should be started 8 weeks after the last administration. The treatment is accompanied by a diet rich in protein. NPP has a shorter ester than Deca, requiring more frequent injections (every 2-3 days).

Nandrolone is an anabolic steroid. It works by increasing the growth of certain tissues in the body and has been shown to improve the oxygen-carrying ability of blood by increasing hemoglobin and the size of red blood cells. The positive effects of Nandrolone include muscle growth, appetite stimulation, increased red blood cell production, and improved bone density. Clinical studies have shown it to be effective in treating anemia, osteoporosis, and some forms of neoplasia including breast cancer, and it also acts as a progestin-based contraceptive. Because nandrolone is not broken down into DHT, the deleterious effects common to most anabolic steroids on the scalp, skin, and prostate are lessened to a degree.